
bt_headshoulder_sharpeopt_mixed
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -60 Days active 408 …
tickers: EXPE, FANG, TSLA, CLB, CIEN, C, TER, ILMN
source: Benzinga
ticker | polarity | why? |
---|---|---|
EXPE | positively | Expedia Group’s (EXPE) stock is likely to be positively affected by the increased price target from Truist Securities, as it indicates a more optimistic outlook on the company’s future performance and potential for growth. This revised target suggests that analysts are seeing positive indicators in the company’s fundamentals or industry trends, which could boost investor confidence and drive the stock price higher. Additionally, the Hold rating indicates stability, which can attract investors looking for steady returns. |
FANG | positively | The reduction in the price target for Diamondback Energy, Inc. (FANG) from $245 to $214, while maintaining a Strong Buy rating, could suggest a relatively high expected profit in an absolute sense. The price decrease in the market could encourage new buyers to enter. These factors could lead to a positive outlook for FANG, however, the lowered price target could result in a very identical fundamental change of the stock as the Strong Buy rating remains unchanged. |
TSLA | positively | The recent price target reduction for Tesla (TSLA) by JP Morgan from $135 to $120, along with maintaining an Underweight rating, could potentially drive investor sentiment to be more cautious. This adjustment might create a buying opportunity for value investors who see the stock as undervalued at the new target. Additionally, the market might view this as an overreaction, leading to a potential rebound in the stock price as investors reassess Tesla’s fundamentals and future growth prospects. |
CLB | positively | The ticker CLB (Core Laboratories Inc.) will be positively affected as Citigroup raised their price target from $15 to $16, indicating a more optimistic outlook on the company’s future performance. Additionally, the upgrade from a Sell to Neutral rating suggests a shift in sentiment, which could attract more investors and drive up the stock price. |
CIEN | positively | B. Riley Securities’ lowered price target for Ciena Corporation (CIEN) from $97 to $89, while maintaining a Buy rating, suggests that the analyst sees significant upside potential despite the reduced target. This adjustment to the price target indicates optimism about the stock, it is only moved 16 dollar-point downward and still presents a favourable outlook for investors. |
C | positively | Based on the context, a positive effect on ticker COP could potentially be influenced by market sentiment spreading from other sectors that are also experiencing macro headwinds. Arvinas’ significant price target reduction may result in broader market concern over energy sector stability but could lead to opportunities for COP if they pivot to renewable energy initiatives to capitalize on the favorable trends observed in Cisco’s improved target. |
TER | positively | The mention of Teradyne, Inc. (TER) having it’s ticker target price lowered would likely be negatively affecting the company since many view a lower target as a bearish outlook. Susquehanna lowering the target would likely deter investors from investing, as the price target for TER has now been significantly reduced. This also indicates a stall in a stocks performance as if a business was performing well the target price would have been increased accordingly. |
ILMN | positively | The price target reduction might indicate concern over immediate earnings and valuation. However, RBC Capital’s maintaining an “Outperform” rating shows they believe the Medical Devices industry’s favorable for the ticker ILMN long-term fundamentals can drive the shares to reach or exceed $128. |
newstrader , finnhub-recommendations
Top Wall Street analysts have revised their outlook on several prominent stocks. Here’s a summary of the latest changes in price targets and ratings:
B. Riley Securities lowered their price target for Ciena Corporation from $97 to $89. Analyst Dave Kang maintained a Buy rating. Ciena shares closed at $63.95 on Tuesday.
Truist Securities increased their price target for Expedia Group from $163 to $175. Analyst Greg Miller kept a Hold rating. Expedia shares closed at $163.75 on Tuesday.
JP Morgan cut their price target for Tesla from $135 to $120. Analyst Ryan Brinkman maintained an Underweight rating. Tesla shares closed at $230.58 on Tuesday.
Raymond James reduced their price target for Diamondback Energy from $245 to $214. Analyst John Freeman maintained a Strong Buy rating. Diamondback Energy shares closed at $144.65 on Tuesday.
DA Davidson cut their price target for RumbleOn from $5 to $4. Analyst Michael Baker maintained a Neutral rating. RumbleOn shares closed at $3.59 on Tuesday.
Susquehanna lowered their price target for Teradyne from $165 to $155. Analyst Mehdi Hosseini maintained a Positive rating. Teradyne shares settled at $87.07 on Tuesday.
RBC Capital slashed their price target for Illumina from $247 to $128. Analyst Conor McNamara maintained an Outperform rating. Illumina shares closed at $84.52 on Tuesday.
Macquarie cut their price target for Vail Resorts from $195 to $185. Analyst Paul Golding maintained a Neutral rating. Vail Resorts shares closed at $165.42 on Tuesday.
Wedbush reduced their price target for Arvinas from $57 to $12 and downgraded the stock from Outperform to Neutral. Arvinas shares settled at $8.30 on Tuesday.
Citigroup raised their price target for Core Laboratories from $15 to $16. Analyst Scott Gruber upgraded the stock from Sell to Neutral. Core Laboratories shares closed at $14.62 on Tuesday.
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -60 Days active 408 …
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. -85 Days active 427 …
Introduction to our strategy no description yet Quick Summary Metric Value Return % p.a. 19 Days active 410 …